Pass it On: It’s National Ovarian Cancer Awareness Month


In 2016, the American Cancer Association estimates that 22,280 women will be diagnosed with ovarian cancer, and 14,240 women will die from the disease. The incidence of ovarian cancer has decreased slightly in the past decade or so, though the reason for this decrease remains unknown.

Ovarian cancer usually has no obvious symptoms but some women may experience bloating, pelvic or abdominal pain, urinary frequency or urgency, and difficulty eating. However, family history of breast or ovarian cancer increases risk of developing ovarian cancer. With an estimated 22,280 new diagnoses of ovarian cancer in 2016, it’s the second most diagnosed gynecological cancer, but produces the most fatalities. The most important risk factor is a strong family history of breast or ovarian cancer, and determining if your hereditary risk can be assessed with genetic testing. Learn more about genetic testing in this recent article, It’s in the Genes. You can also join the conversation with other individuals dealing with hereditary cancer risk in the hereditary breast and ovarian cancer syndrome support group on CancerConnect here.

More on Ovarian Cancer

Faces of Hope: Ovarian Cancer Advocates Speak Out

Special Report: Ovarian Cancer

What You Need to Know about Ovarian Cancer Risk, Detection, and Prevention

Newly Diagnosed with Ovarian Cancer? Start Here.

Ovarian Cancer Information Center

10 Things Every Woman Should Know About Ovarian Cancer

Join the Conversation

Ovarian Cancer Online Support Group

Have a Question about Genetic Testing and Ovarian Cancer? Ask the Expert!

The National Ovarian Cancer Coalition Presents: Genetic Testing and Ovarian Cancer – It’s Personal

Live Webinar on Thursday, September 28th 7:00 – 8:00 p.m. EST

Join the NOCC for a live Ask the Expert session with Duke Cancer Institute’s gynecologic oncology expert Angeles Secord, MD in the NOCC CancerConnect Community on Thursday, September 28th from 7:00 – 8:00 p.m. EDT. Click here to submit your question.

Ovarian Cancer Research News

FDA Accepts Priority Review of Rucaparib For The Treatment Of Advanced Mutant BRCA Ovarian Cancer

SGO, ASCO Issue New Guidelines for Ovarian Cancer Treatment

T-Cells Can be Directed to Treat a Variety of Ovarian Cancers

Niraparib Improves Progression-Free Survival in Ovarian Cancer

Sign up for monthy updates on ovarian cancer research news, tips, and community discussions here.

Copyright © 2017 CancerConnect. All Rights Reserved.